In order to study the structure–activity relationship (SAR) of C21-steroidal glycosides toward human cancer cell lines and explore more potential anticancer agents, a series of 3β-O-neoglycosides of caudatin and its analogues were synthesized. The results revealed that most of peracetylated 3β-O-monoglycosides demonstrated moderate to significant antiproliferative activities against four human cancer
为研究C 21 -甾体苷对人癌
细胞系的构效关系(
SAR),探索更多潜在的抗癌药物,合成了一系列3β -O-尾苷及其类似物的新苷类。结果显示,大多数过乙酰化 3β-O-
单糖苷对四种人类癌
细胞系(MCF-7、HCT-116、HeLa 和 HepG2)表现出中度至显着的抗增殖活性。其中,3β-O-(2,3,4-tri-O-acetyl-β-L-glucopyranosyl)-caudatin ( 2 k ) 对HepG2细胞的抗增殖活性最高,IC 50值为3.11 μM。机械研究表明,化合物2k以剂量依赖性方式诱导细胞凋亡和细胞周期停滞在 S 期。总体而言,这些目前的研究结果表明,糖基化是一种有前途的支架,可以提高天然存在的 C 21 -甾体糖苷配基的抗癌活性,而化合物2k代表了一种值得进一步研究的潜在抗癌剂。